Medical Device ETF in Focus as Medtronic Buys Covidien

Medtronic agreed to buy Irish rival Covidien for $42.9 billion. Investors looking to tap this opportunity should consider the medical device ETF.



from Content Keyword RSS http://ift.tt/1lskT3O

via IFTTT